Palvella Therapeutics, Inc. (PVLA)

NCM – Real Time Price. Currency in USD

125.79

+3.70 (3.03%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

26M

Cost of goods sold

-3M

Gross Profit

23M

Operating expenses (excl. COGS)

-39M

-14M

-12M

-67M

Operating Income

-39M

-14M

-12M

-43M

Non-operating income, total

-3M

31M

10M

Pretax income

-42M

-17M

19M

-33M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-42M

-17M

19M

-33M

Palvella Therapeutics, Inc. (PVLA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Palvella Therapeutics, Inc. (PVLA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Palvella Therapeutics, Inc. (PVLA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Palvella Therapeutics, Inc. (PVLA)

Income Statement (Annual)

Income Statement (Annual)